Retina Eye Center

10/22/2026

Gene therapy may offer a new way to treat X-linked retinoschisis (XLRS), a rare inherited retinal disease. In a small clinical trial, treated eyes showed improvements in the retina and in vision over the following year. While more research is needed, the early results are encouraging. Learn more: https://brnw.ch/21x6BFx

X-linked retinoschisis is a recessive disease characterized by progressive macular degeneration and vision loss due to pathogenic variation in RS1. We administered a single subretinal injection of ...

10/20/2026

At The Retina Eye Center, we believe patients do best when they’re active partners in their treatment. Coming to your retina appointment prepared with questions can help you better understand your diagnosis, treatment options, and what to expect moving forward. Our latest blog breaks down key questions to consider asking at your next appointment: https://brnw.ch/21x6y00

10/15/2026

A recent study found that changes in the tiny blood vessels behind the retina (choriocapillaris) may begin as early as prediabetes and continue as diabetes progresses. These findings could help doctors better understand and monitor how diabetes affects the eyes. Read the full study: https://brnw.ch/21x6qHd

To characterize macular microvascular alterations across the dysglycemia spectrum, from prediabetes (pre-DM) to early type 2 diabetes (T2DM), before clinically detectable diabetic retinopathy develops. In this cross-sectional study, participants ...

10/13/2026

Uveitis is inflammation of the eye's middle layer, often linked to autoimmune conditions, past eye injury or surgery, or smoking. Left untreated, uveitis can lead to permanent vision loss, but with early intervention, most patients respond well to treatment. Our specialists treat all subtypes of uveitis. Learn more: https://brnw.ch/21x6nFT

10/08/2026

This World Sight Day, we’re reminding you to stay proactive about your eye health. Early detection and timely care can help protect your vision from retinal disease. If you have concerns about your retinal health, our team is here to help: https://brnw.ch/21x6gDW

10/06/2026

Researchers have developed a new tool called TIGRa that may help protect the nerve cells in the eye that are damaged by glaucoma and other conditions. In a study with mice, the treatment helped preserve more vision after retinal injury. Learn more: https://brnw.ch/21x6ctW

Liu and colleagues developed TIGRa, an ultra-compact programmable gene activator that efficiently regulates multiple genes from a single construct. TIGRa supports cellular reprogramming and, when delivered by a single AAV, protects retinal neurons and preserves vision, highlighting its potential for...

10/01/2026

Meet Dr. Ranjit Dhaliwal, a highly experienced ophthalmologist specializing in the evaluation and treatment of retinal diseases, including medical retina and vitreoretinal surgery. With decades of experience, he has contributed to peer-reviewed research, authored chapters in medical books, and continues to share his expertise through conferences and academic teaching. Learn more: https://brnw.ch/21x65Ou

09/29/2026

AI is creating new possibilities across ophthalmology, from helping researchers identify disease earlier to making retinal imaging and clinical trials more efficient. Retina specialists discuss how AI is being used in research and patient care. Learn more: https://brnw.ch/21x62t3

AI accelerates retina trials and imaging insights, boosts screening access, and raises urgent questions on regulation, privacy, and equity.

09/28/2026

World Retina Day is an opportunity to raise awareness about retinal health and the steps we can take to protect our vision. Regular eye exams and paying attention to changes in your vision can help you stay proactive about protecting your sight.

09/22/2026

Facing eye injections can feel intimidating, but they are a standard, highly targeted way to protect your vision. Discover how this procedure works and what to expect throughout your treatment journey: https://brnw.ch/21x5Sjk

For many conditions, intravitreal injections of Avastin, Eylea, or Lucentis are an effective treatment option. Schedule a consult with The Retina Eye Center in Augusta and Aiken.